Agilent Technologies Interest Paid decreased by 97.8% to $1.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 66.7%, from $3.00M to $1.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 7.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.00M | $17.00M | $23.00M | $18.00M | $22.00M | $16.00M | $29.00M | $15.00M | $29.00M | $16.00M | $29.00M | $14.00M | $26.00M | $10.00M | $30.00M | $3.00M | $48.00M | $4.00M | $46.00M | $1.00M |
| QoQ Change | — | +0.0% | +35.3% | -21.7% | +22.2% | -27.3% | +81.3% | -48.3% | +93.3% | -44.8% | +81.3% | -51.7% | +85.7% | -61.5% | +200.0% | -90.0% | >999% | -91.7% | >999% | -97.8% |
| YoY Change | — | — | — | — | +29.4% | -5.9% | +26.1% | -16.7% | +31.8% | +0.0% | +0.0% | -6.7% | -10.3% | -37.5% | +3.4% | -78.6% | +84.6% | -60.0% | +53.3% | -66.7% |